Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

July 2018
1. FERRANDINO F, Bernardini G, Tsaouli G, Grazioli P, et al
   Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
   Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0401.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. ZHANG Y, Zhou X, Li Y, Xu Y, et al
   Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
   Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0333.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. PINAZZA M, Ghisi M, Minuzzo S, Agnusdei V, et al
   Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
   Oncogene. 2018 Apr 12. pii: 10.1038/s41388-018-0234.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. ZHU Y, Lu L, Qiao C, Shan Y, et al
   Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
   Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0157.
   PubMed     Text format     Abstract available
   
   
   February 2018
5. ABDUL-AZIZ AM, Shafat MS, Sun Y, Marlein CR, et al
   HIF1alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
   Oncogene. 2018 Feb 28. pii: 10.1038/s41388-018-0151.
   PubMed     Text format     Abstract available
   
   
   
6. DI COSTANZO A, Del Gaudio N, Conte L, Dell'Aversana C, et al
   The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
   Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0143.
   PubMed     Text format     Abstract available
   
   
   
7. WANG H, Bei L, Shah CA, Huang W, et al
   The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
   Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
   PubMed     Text format     Abstract available
   
   
   October 2017
8. HEYDT Q, Larrue C, Saland E, Bertoli S, et al
   Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
   Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
   PubMed     Text format     Abstract available
   
   
   
9. ABBACI A, Talbot H, Saada S, Gachard N, et al
   Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
   Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
   PubMed     Text format     Abstract available
   
   
   September 2017
10. SERIO J, Ropa J, Chen W, Mysliwski M, et al
    The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
11. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    August 2017
12. D'ABUNDO L, Callegari E, Bresin A, Chillemi A, et al
    Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
13. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
14. ZIMMERMANNOVA O, Doktorova E, Stuchly J, Kanderova V, et al
    An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
15. KANG SM, Rosales JL, Meier-Stephenson V, Kim S, et al
    Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
16. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Text format     Abstract available
    
    
    
17. TSURUTA-KISHINO T, Koya J, Kataoka K, Narukawa K, et al
    Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Oncogene. 2017;36:3300-3311.
    PubMed     Text format     Abstract available
    
    
    April 2017
18. BURGESS M, Mapp S, Mazzieri R, Cheung C, et al
    Increased FcgammaRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
    Oncogene. 2017;36:2366-2376.
    PubMed     Text format     Abstract available
    
    
    
19. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
20. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available
    
    
    March 2017
21. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Text format     Abstract available
    
    
    
22. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
23. FERREIRA HJ, Heyn H, Vizoso M, Moutinho C, et al
    DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format    
    
    
    February 2017
24. VAN ATTEKUM MH, Terpstra S, Slinger E, von Lindern M, et al
    Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
25. WAKIM J, Arman E, Becker-Herman S, Kramer MP, et al
    The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    January 2017
26. PRANGE KH, Mandoli A, Kuznetsova T, Wang SY, et al
    MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
27. UGALE A, Sawen P, Dudenhoffer-Pfeifer M, Wahlestedt M, et al
    MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    December 2016
28. POMEROY EJ, Lee LA, Lee RD, Schirm DK, et al
    Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
29. SAFFERTHAL C, Rohde K, Fulda S
    Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
30. GOYAMA S, Shrestha M, Schibler J, Rosenfeldt L, et al
    Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
31. SMITH CI
    From identification of the BTK kinase to effective management of leukemia.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
32. STAFFAS A, Arabanian LS, Wei SY, Jansson A, et al
    Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Oncogene. 2016 Sep 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
33. HU Y, Su H, Liu C, Wang Z, et al
    DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
34. LEE-SHERICK AB, Eisenman KM, Sather S, McGranahan A, et al
    Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    
    
    
    June 2016
35. ELF S, Lin R, Xia S, Pan Y, et al
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
36. BERNASCONI-ELIAS P, Hu T, Jenkins D, Firestone B, et al
    Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
37. SU R, Dong L, Zou D, Zhao H, et al
    microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    
38. LIU PP, Liu J, Jiang WQ, Carew JS, et al
    Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    February 2016
39. SLANY RK
    The molecular mechanics of mixed lineage leukemia.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
40. RODRIGUEZ-PERALES S, Torres-Ruiz R, Suela J, Acquadro F, et al
    Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
    Oncogene. 2016;35:125-34.
    PubMed     Text format     Abstract available
    
    
    
41. WIMMER P, Berscheminski J, Blanchette P, Groitl P, et al
    PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Oncogene. 2016;35:69-82.
    PubMed     Text format     Abstract available
    
    
    December 2015
42. ZHAO Y, Masiello D, McMillian M, Nguyen C, et al
    CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.
    Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    
    November 2015
43. MARJON KD, Termini CM, Karlen KL, Saito-Reis C, et al
    Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
    Oncogene. 2015 Nov 23. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available
    
    
    September 2015
44. SHAIN KH, Dalton WS, Tao J
    The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
    Oncogene. 2015;34:4673-82.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: